A citation-based method for searching scientific literature

Siwei Zhang, Shanshan Wu, Yun Wan, Yongsong Ye, Ying Zhang, Zelan Ma, Quanlan Guo, Hongdan Zhang, Li Xu. Eur Radiol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Conventional MR-based Preoperative Nomograms for Prediction of IDH/1p19q Subtype in Low-Grade Glioma.
Zhenyin Liu, Tao Zhang, Hua Jiang, Wenchan Xu, Jing Zhang. Acad Radiol 2019
14
50

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
Michael Weller, Ruthild G Weber, Edith Willscher, Vera Riehmer, Bettina Hentschel, Markus Kreuz, Jörg Felsberg, Ulrike Beyer, Henry Löffler-Wirth, Kerstin Kaulich,[...]. Acta Neuropathol 2015
192
50

Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.
Artemiy S Silantyev, Luca Falzone, Massimo Libra, Olga I Gurina, Karina Sh Kardashova, Taxiarchis K Nikolouzakis, Alexander E Nosyrev, Christopher W Sutton, Panayiotis D. Mitsias, Aristides Tsatsakis. Cells 2019
98
50


Radiogenomics of lung cancer.
Chi Wah Wong, Ammar Chaudhry. J Thorac Dis 2020
11
50

Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma.
Lisandra Muñoz-Hidalgo, Teresa San-Miguel, Javier Megías, Daniel Monleón, Lara Navarro, Pedro Roldán, Miguel Cerdá-Nicolás, Concha López-Ginés. Neoplasia 2020
20
50

Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Ricky Chen, Adam L Cohen, Howard Colman. Curr Treat Options Oncol 2016
75
50

Radiomics and radiogenomics for precision radiotherapy.
Jia Wu, Khin Khin Tha, Lei Xing, Ruijiang Li. J Radiat Res 2018
53
50

MRI features predict survival and molecular markers in diffuse lower-grade gliomas.
Hao Zhou, Martin Vallières, Harrison X Bai, Chang Su, Haiyun Tang, Derek Oldridge, Zishu Zhang, Bo Xiao, Weihua Liao, Yongguang Tao,[...]. Neuro Oncol 2017
182
50

Multilevel research and the challenges of implementing genomic medicine.
Muin J Khoury, Ralph J Coates, Mary L Fennell, Russell E Glasgow, Maren T Scheuner, Sheri D Schully, Marc S Williams, Steven B Clauser. J Natl Cancer Inst Monogr 2012
34
50

Radiomics and radiogenomics in lung cancer: A review for the clinician.
Rajat Thawani, Michael McLane, Niha Beig, Soumya Ghose, Prateek Prasanna, Vamsidhar Velcheti, Anant Madabhushi. Lung Cancer 2018
235
50

Prospects and problems for standardizing model validation in systems biology.
Fridolin Gross, Miles MacLeod. Prog Biophys Mol Biol 2017
6
50

Lower-Grade Gliomas: Predicting DNA Methylation Subtyping and its Consequences on Survival with MR Features.
Hongdan Zhang, Li Xu, Zhiping Zhong, Yupin Liu, Yu Long, Shuqin Zhou. Acad Radiol 2021
1
100

Development and Validation of a Nomogram Prognostic Model for SCLC Patients.
Shidan Wang, Lin Yang, Bo Ci, Matthew Maclean, David E Gerber, Guanghua Xiao, Yang Xie. J Thorac Oncol 2018
86
50


Applications and limitations of radiomics.
Stephen S F Yip, Hugo J W L Aerts. Phys Med Biol 2016
534
50

Beyond imaging: The promise of radiomics.
Michele Avanzo, Joseph Stancanello, Issam El Naqa. Phys Med 2017
231
50

Noninvasively Evaluating the Grading of Glioma by Multiparametric Magnetic Resonance Imaging.
Lei Zhang, Liu-Qing Yang, Li Wen, Sheng-Qing Lv, Jun-Hao Hu, Qing-Rui Li, Jian-Ping Xu, Ru-Fu Xu, Dong Zhang. Acad Radiol 2021
4
50

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
50

The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model.
Mark van der Gaag, Tonko Hoffman, Mila Remijsen, Ron Hijman, Lieuwe de Haan, Berno van Meijel, Peter N van Harten, Lucia Valmaggia, Marc de Hert, Anke Cuijpers,[...]. Schizophr Res 2006
364
50

The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges.
Zhenyu Liu, Shuo Wang, Di Dong, Jingwei Wei, Cheng Fang, Xuezhi Zhou, Kai Sun, Longfei Li, Bo Li, Meiyun Wang,[...]. Theranostics 2019
294
50

Radiomics in medical imaging-"how-to" guide and critical reflection.
Janita E van Timmeren, Davide Cester, Stephanie Tanadini-Lang, Hatem Alkadhi, Bettina Baessler. Insights Imaging 2020
235
50

Personalized medicine: motivation, challenges, and progress.
Laura H Goetz, Nicholas J Schork. Fertil Steril 2018
100
50

DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model.
Zisheng Chen, Shan Xiong, Jianfu Li, Limin Ou, Caichen Li, Jinsheng Tao, Zeyu Jiang, Jianbing Fan, Jianxing He, Wenhua Liang. Transl Lung Cancer Res 2020
11
50

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Y-P Chen, Y-Q Wang, J-W Lv, Y-Q Li, M L K Chua, Q-T Le, N Lee, A Dimitrios Colevas, T Seiwert, D N Hayes,[...]. Ann Oncol 2019
133
50


Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Rui-Chao Chai, Ke-Nan Zhang, Yu-Zhou Chang, Fan Wu, Yu-Qing Liu, Zheng Zhao, Kuan-Yu Wang, Yuan-Hao Chang, Tao Jiang, Yong-Zhi Wang. Carcinogenesis 2019
33
50

An evolving view of copy number variants.
Stephanie Lauer, David Gresham. Curr Genet 2019
38
50


Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in 18 F-FDG PET/CT.
Yuquan Zhang, Chao Cheng, Zhaobang Liu, Lei Wang, Guixia Pan, Gaofeng Sun, Yan Chang, Changjing Zuo, Xiaodong Yang. Med Phys 2019
33
50

Radiomics for Distinguishing Myocardial Infarction from Myocarditis at Late Gadolinium Enhancement at MRI: Comparison with Subjective Visual Analysis.
Tommaso Di Noto, Jochen von Spiczak, Manoj Mannil, Elena Gantert, Paolo Soda, Robert Manka, Hatem Alkadhi. Radiol Cardiothorac Imaging 2019
9
50

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
50

A map of human genome variation from population-scale sequencing.
Gonçalo R Abecasis, David Altshuler, Adam Auton, Lisa D Brooks, Richard M Durbin, Richard A Gibbs, Matt E Hurles, Gil A McVean. Nature 2010
50

A Review of Radiomics and Deep Predictive Modeling in Glioma Characterization.
Sonal Gore, Tanay Chougule, Jayant Jagtap, Jitender Saini, Madhura Ingalhalikar. Acad Radiol 2021
21
50

Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine.
Susan M Chang, Daniel P Cahill, Kenneth D Aldape, Minesh P Mehta. Am Soc Clin Oncol Educ Book 2016
14
50

Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
Xiaorong Peng, Chen Yishuang, Zhan Kaizhou, Liqun Xiao, Chunnong Ma. J Comput Assist Tomogr 2019
8
50

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.
Martinus P G Broen, Marion Smits, Maarten M J Wijnenga, Hendrikus J Dubbink, Monique H M E Anten, Olaf E M G Schijns, Jan Beckervordersandforth, Alida A Postma, Martin J van den Bent. Neuro Oncol 2018
94
50

Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies.
P D Delgado-López, E M Corrales-García, J Martino, E Lastra-Aras, M T Dueñas-Polo. Clin Transl Oncol 2017
64
50

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Eric Bouffet, Valérie Larouche, Brittany B Campbell, Daniele Merico, Richard de Borja, Melyssa Aronson, Carol Durno, Joerg Krueger, Vanja Cabric, Vijay Ramaswamy,[...]. J Clin Oncol 2016
531
50

CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.
Peter A Prieto, James C Yang, Richard M Sherry, Marybeth S Hughes, Udai S Kammula, Donald E White, Catherine L Levy, Steven A Rosenberg, Giao Q Phan. Clin Cancer Res 2012
375
50

The management of low-grade gliomas in adults.
Ramin A Morshed, Jacob S Young, Shawn L Hervey-Jumper, Mitchel S Berger. J Neurosurg Sci 2019
26
50

Development and assessment of an individualized nomogram to predict colorectal cancer liver metastases.
Mingyang Li, Xueyan Li, Yu Guo, Zheng Miao, Xiaoming Liu, Shuxu Guo, Huimao Zhang. Quant Imaging Med Surg 2020
16
50

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
Nicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, Sofie Ramskov, Rikke Lyngaa, Sunil Kumar Saini, Mariam Jamal-Hanjani, Gareth A Wilson, Nicolai J Birkbak, Crispin T Hiley,[...]. Science 2016
50


Tumor mutational burden is associated with poor outcomes in diffuse glioma.
Lihong Wang, Jia Ge, Yang Lan, Yu Shi, Ying Luo, Yuhuan Tan, Mei Liang, Song Deng, Xia Zhang, Wenying Wang,[...]. BMC Cancer 2020
32
50

An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomas.
Jingtao Wang, Xuejun Zheng, Jinling Zhang, Hao Xue, Lijie Wang, Rui Jing, Shuo Chen, Fengyuan Che, Xueyuan Heng, Gang Li,[...]. Eur Radiol 2021
14
50

Radiogenomics: bridging imaging and genomics.
Zuhir Bodalal, Stefano Trebeschi, Thi Dan Linh Nguyen-Kim, Winnie Schats, Regina Beets-Tan. Abdom Radiol (NY) 2019
104
50

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Zachary R Chalmers, Caitlin F Connelly, David Fabrizio, Laurie Gay, Siraj M Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki,[...]. Genome Med 2017
50


Diffuse low-grade gliomas.
Asgeir Store Jakola, Geirmund Unsgård, Roar Kloster, Ole Solheim. J Neurosurg 2013
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.